Berkeley Lights

General Information
Business:

 

Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. This is a new way to capture and interpret the qualitative language of biology and translate it into single-cell specific digital information, referred to as Digital Cell Biology. We currently focus on enabling the large and rapidly growing markets of antibody therapeutics, cell therapy and synthetic biology with our platform. 

Industry: LABORATORY ANALYTICAL INSTRUMENTS
Employees: 210
Founded: 2011
Contact Information
Address 5858 Horton Street, Suite 320, Emeryville, CA 94608, US
Phone Number (510) 858-2855
Web Address http://www.berkeleylights.com
View Prospectus: Berkeley Lights
Financial Information
Market Cap $1356.1mil
Revenues $57.8 mil (last 12 months)
Net Income $-22.5 mil (last 12 months)
IPO Profile
Symbol BLI
Exchange NASDAQ
Shares (millions): 8.1
Price range $22.00 - $22.00
Est. $ Volume $178.2 mil
Manager / Joint Managers J.P. Morgan/ Morgan Stanley/ Cowen and Company
CO-Managers William Blair
Expected To Trade: 7/17/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change